)
Tandem Diabetes Care (TNDM) investor relations material
Tandem Diabetes Care Piper Sandler 37th Annual Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Pricing and revenue growth
Achieved 5% revenue growth in Q3 from pricing, primarily in the US, driven by pharmacy and DME benefits, with two-thirds of the uplift from pharmacy and one-third from DME.
Pharmacy sales accounted for about 5% of US sales, with significant dollar impact despite small volumes due to higher pricing.
Coverage for Mobi Pump and supplies in pharmacy reached 40% of US lives, with t:slim supplies rapidly approaching that level.
Pricing uplift could represent a multi-year tailwind, potentially adding $50 million annually and driving both top-line and margin improvements.
Gross margin improved to 53%-54% in 2023, with a target to exit 2026 at 60%, driven by price increases and pharmacy channel expansion.
Product innovation and pipeline
Focused on expanding pump adoption among MDI and type 2 diabetes patients, with type 2 seen as a multi-year market development opportunity.
Control-IQ Plus algorithm simplifies onboarding and dosing, enhancing competitive position for type 2 patients.
Mobi Patch Pump, offering up to 7-day wear and tubeless use, launches in 2026, with Sigi technology enabling further miniaturization for future generations.
Integration with Android and FreeStyle Libre 3 expands addressable market and user flexibility.
Fully closed-loop system pivotal trial starts in 2026, with commercial launch expected about 18 months later.
Market strategy and competitive positioning
Pharmacy channel expansion aims to reduce patient out-of-pocket costs and increase pump adoption.
Patch pump segment seen as a market-expanding opportunity, targeting both new patients and those seeking more flexibility.
Sigi acquisition supports next-gen Mobi development, focusing on miniaturization and ergonomic improvements.
International strategy includes direct operations in select markets, with direct sales expected to grow from less than 5% to 15% of OUS sales next year.
Sales force expanded and optimized to target high prescribers, with current structure seen as sufficient for upcoming launches.
Next Tandem Diabetes Care earnings date
Next Tandem Diabetes Care earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)